Sandoz Canada Inc.

14 articles about Sandoz Canada Inc.

• Advisory - Multiple lots of irbesartan, losartan and valsartan drugs recalled

  10/2/2021

  Auro Pharma Inc. is recalling seven lots of prescription losartan tablets, in 25 mg, 50 mg and 100 mg strengths, after tests found an azido impurity (5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H tetrazole) above the acceptable limit.

• Alberta’s biosimilars policy: another significant step towards improving patient access to safe, effective, and high-quality medicines in Canada

  12/12/2019

  The province’s biosimilars policy could contribute to important healthcare savings

• Sandoz Canada launches two new generic therapies for hypertension

  3/7/2018

  Sandoz Canada announced that it has launched two new generic alternatives to therapies that have been available under the brand names Coversyl and Coversyl Plus for the treatment of hypertension.

• Erelzi (Etanercept), By Sandoz Canada, Is Now Available For Patients In Canada For The Treatment Of Multiple Inflammatory Diseases

  8/21/2017

• Sandoz Canada Release: Sandoz Erelzi (Etanercept) Receives Positive Reimbursement Recommendation From Common Drug Review For Treatment Of Multiple Inflammatory Diseases

  8/2/2017

• Sandoz Canada Launches Prsandoz Duloxetine, A Generic Version Of Cymbalta*, For The Treatment Of Depression And Anxiety Symptoms

  5/18/2016

• Sandoz Canada Launches Prtobramycin INHALATION SOLUTION, A Generic Version Of Prtobi Indicated For Pulmonary Infections In Cystic Fibrosis Patients

  3/31/2016

• Sandoz Canada Expands Its Cancer Medication Portfolio With The Launch Of (PR) Oxaliplatin Injection

  2/5/2016

• Sandoz Canada Launches Two Easy-To-Use Products: Salinex Seawater Nasal Spray For Daily Care And Ezeva Zinc Oxide Cream

  12/8/2015

• Sandoz Canada Launches A New Concentration Of T/Clorazepam Injection USP

  12/3/2015

• Sandoz Canada Launches New Multi-Platform Application To Show Real-Time Availability Of Its Injectable Medicines

  10/15/2015

• Sandoz Canada Launches PrSandoz Solifenacin On The Canadian Market For The Treatment Of Urinary Urgency, Frequency And Incontinence

  10/8/2015

• Sandoz Canada Release: Health Canada Approves New Indications For Promnitrope (Somatropin), Canada's First Subsequent Entry Biologic (Biosimilar)

  9/3/2015

• Sandoz Canada Launches Pramiodarone Syringe For The Treatment Of Several Heart Rhythm Disorders

  8/21/2015